With the growth of investment opportunities in the cannabis space, it was only natural for the rise of exchange-traded funds (ETFs) to appear.

The public marijuana market has seen the creation of a few leading ETFs that have allowed investors to gain a broad entry into the pot stocks game, without committing to one specific stock.

ETFs offer investors a tracking stock index that can be traded in a public stock market.

Due to the extreme volatility in the overall marijuana stocks space, these ETFs are still targets to the ups and downs of any given trading day. The marijuana stock market has been prone to wide swings in trading volumes leading to large increases or decreases in value.

Instead of navigating the space for individual stocks, ETFs offer investors an alternative by removing the option on which stocks to buy thanks to their assets.

These ETFs have also served as a referendum on the state of the marijuana industry, showing its peaks and declines, depending on the market.

Despite some of the similar investing concepts, these stocks and ETFs can be found across stock exchange options in the Canadian market.

Here, the Investing News Network (INN) presents a guide on the market for cannabis-centric ETFs and which to follow in 2019.

1. Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ)

Horizons ETFs broke ground in 2017 when it launched the first ETF with an exclusive focus on marijuana stocks.

“It wasn’t until sort of the early part of 2017 were we felt there was enough names at the time about 15 stocks to allow us to launch an ETF that would give everyone a one ticket diversified solution to buying marijuana stocks,” Mark Noble, senior vice president of ETF strategy with Horizons ETFs previously told INN.

The index crossed the C$1 billion mark in assets under management in the fund last September.

“HMMJ’s growth has far exceeded our expectations as investors have strongly supported the sector in anticipation of Canada’s upcoming recreational marijuana legalization,” Steve Hawkins, president and CEO of Horizons ETFs, said in a press release.

Some of the recent top stocks in this fund include: Canopy Growth (NYSE:CGC,TSX:WEED), Cronos Group (NASDAQ:CRON,TSX:CRON) and GW Pharmaceuticals (NASDAQ:GWPH).

2. Purpose Marijuana Opportunities Fund (NEO:MJJ)

This fund offers investors trading with an expert voice in hand. The fund is actively managed by Greg Taylor, chief investment officer of Purpose Investments, as a way to combat the risk attached with these stocks.

In February, it was revealed the fund had managed to create returns of 53.43 percent over a one-year time frame since its inception in January 2018.

The firm heavily credited the active management status of the fund as the reason for its gains.

Some of these funds current top stocks include: Organigram Holdings (TSX:OGI,OTCQX:OGRMF), Aurora Cannabis (NYSE:ACB,TSX:ACB) and Hexo (NYSEAMERICAN:HEXO,TSX:HEXO).

“It’s going to be important to run nimble, make sure that you’re not just blindly buying stocks in the sector and not watching them, because there are going to be sudden moves which might catch people off guard,” Taylor previously told INN.

3. Evolve Marijuana ETF (TSX:SEED)

Evolve ETFs also offers a cannabis focussed ETF to investors. Launched in February 2018, this fund currently counts with 25 stocks in its holdings list.

In March, the firm announced SEED secured a return of 48.48 percent for a one-year period ending in February 28.

“The regulatory landscape in marijuana is developing rapidly as the rules around retail distribution take shape this year,” Elliot Johnson, chief investment officer at Evolve ETFs and portfolio manager for SEED, said.

Johnson credited the active management for the returns of this fund and added this style will be “essential” when picking the stocks of the firms that will dominate the global market.

“Our portfolio construction and risk management processes make us well positioned to take advantage of the changes we expect in the coming year,” he said.

Some of these funds current top stocks include: Aurora Cannabis, Aphria (NYSE:APHA,TSX:APHA) and Canopy Growth.

4. Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR)

With the growth Horizons noticed from its first ETF, the firm went ahead and launched a second one to the public market, on the Aequitas NEO Exchange, a smaller stock exchange in Canada.

This fund is focussed on smaller stocks from cannabis companies with a market cap between C$50 million and C$500 million.

The Horizons Emerging Marijuana Growers was launched in February 2018.

The fund was designed to target the growers sector of the market underneath the already established marijuana firms.

“We are more excited about the smaller companies in the space,” Noble told INN last November, due to the large valuations on the bigger licensed producers.

Some of these funds current top stocks include: TerrAscend (CSE:TER,OTCQX:TRSSF), The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) and Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF).

Investor takeaway

All of these cannabis funds enjoy uniqueness in the market since a portfolio manager in the Canadian public market doesn’t see any more marijuana stock-centric indexes launching soon.

“I don’t think there’s enough demand, just right now,” Nawan Butt, portfolio manager with Purpose Investments, previously told INN.

He said the market landscape for marijuana funds is “limiting” when asked about the possibility of his firm launching a second fund in the future.

However, with the emergence of the hemp industry in the US and the continued rise of US-based companies with Canadian cannabis stocks, more funds could appear in the future.


INNdepth

Want more details? Check out these articles for more INNdepth coverage.

Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry


Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in contributed article. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less